Webcast CME

Latest Content - Pediatrics

 Filter Results
Series: (Optional)
Length: (Optional)
Sort by: Latest Top Rated
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
3.66 / 4.00
Testing, Risk Factors and the Clinical Spectrum of Lung Disease for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD; Robert Sandhaus, MD; Lauren Palange, MS
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
3.74 / 4.00
Testing, Prevalence, and Augmentation Therapy for Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Robert Sandhaus, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
3.65 / 4.00
The Epidemiology and Treatment Options for Alpha-1 Antitrypsin Deficiency
Faculty: Umur Hatipoglu, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
3.59 / 4.00
Enhancing Detection, Individualized Treatment Plans, and Insurance Implications of Diagnosing Alpha-1 Antitrypsin Deficiency
Faculty: James Stoller, MD; Charlie Strange, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
3.7 / 4.00
Individualized Treatment Plans, Surgical and bronchoscopic lung volume reduction for Alpha-1 Patients and a Patient Testimonial
Faculty: Thomas Gildea, MD; Michael Campos
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
3.73 / 4.00
Testing, Risk Factors and Missed Diagnosis of Alpha-1 Liver Disease
Faculty: Virginia Clark, MD; Shreya Sengupta, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Liver-Affected Alphas: Case Study, Advanced Disease and Treatment
3.76 / 4.00
Liver-Affected Alphas: Case Study, Advanced Disease and Treatment
Faculty: Charlie Strange, MD; Jeff Teckman, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Portal Hypertension, Hepatitis Vaccines, and the Importance of Family Testing in Patients with Alpha-1 Antitrypsin Deficiency
3.74 / 4.00
Portal Hypertension, Hepatitis Vaccines, and the Importance of Family Testing in Patients with Alpha-1 Antitrypsin Deficiency
Faculty: Charlie Strange, MD; Jeff Teckman, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
Cholestatic and Advanced Liver Disease, Risk Factors, Testing and Treatments in Pediatric Patients with Alpha-1 Antitrypsin Deficiency
3.74 / 4.00
Cholestatic and Advanced Liver Disease, Risk Factors, Testing and Treatments in Pediatric Patients with Alpha-1 Antitrypsin Deficiency
Faculty: Charlie Strange, MD; Jeff Teckman, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025
The Role of the Physician Assistant and Nurse Practitioner in Diagnosing and Managing Patients with Alpha-1 Antitrypsin Deficiency
3.6 / 4.00
The Role of the Physician Assistant and Nurse Practitioner in Diagnosing and Managing Patients with Alpha-1 Antitrypsin Deficiency
Faculty: Teresa Kitchen, RN; Kim Foil, MS; Robert Sandhaus, MD
CME: Yes
Length: 30 minutes
Release Date: 10/25/2022 12:00:00 AM
Expiration Date: 10/25/2025